期刊文献+

一种放射性显影剂的血管刺激性评价及人员辐射防护实践 被引量:3

Evaluation of Vascular Irritation of a Radiocontrast Medium and Practice of Radiation Protection for Personnel
下载PDF
导出
摘要 目的评价一种锝(99m Tc)标记的放射性显影剂的血管性刺激性,并对放射性药物临床前毒理研究中人员辐射防护提出建议。方法对6只新西兰兔静脉注射锝(99mTc)喷替酸盐注射液,评价其血管刺激性,分析实验前后受试物的比活度和放射化学纯度,实验中对主要操作人员进行剂量监测及表面污染监测。结果实验以临床静脉注射最大浓度555 MBq·m L-1,剂量194 MBq·kg^(-1)(临床最大剂量的21倍)静脉给予兔耳缘静脉后未出现药物相关性血管刺激,给药前后受试物的比活度及放射化学纯度均符合要求,所有操作人员个人单次实验有效剂量最大值0.01 m Sv,预估个人年总有效剂量不超过1 m Sv,小于职业照射人员年有效剂量限值20 m Sv。实验后,人员体表及设备表面均未检测到放射性污染。结论放射性药物非临床毒理研究应根据核素性质及标记底物进行合理的剂量设计和防护措施规划,保证实验结果有效性和安全性的同时,严格执行个人剂量监测和污染监测,保障人员辐射安全。 Objective To evaluate the vascular irritation of a 99mTc labeled radiocontrast medium,so as to make suggestions on radioprotection for personnel in the preclinical toxicological study of radiopharmaceuticals.Methods Six New Zealand rabbits were injected with technetium pentetate injection.The specific activity and radiochemical purity of the samples at the start and end of the test were analyzed,and the vascular irritation to the vein was evaluated.Dose monitoring and surface contamination monitoring were carried out during the main processes of the test.Results The maximum concentration of 555 MBq·mL^-1 and the dose of 194 MBq·kg^-1(21 times of the maximum clinical dose)were intravenously administered through the ear-vein of rabbits.There wasn't drug-related vascular stimulation reactions observed in the test.The detection results of samples'specific activity and radiochemical purity both met the test requirements.The individual highest radiation effective dose of single test of all operators was 0.01 mSv.The estimated annual total radiation effective dose is not more than 1 mSv,which is less than the limit of occupational personnel radiation effective dose(20 mSv).What's more,there was no radioactive contamination detected on surface of operators and equipments.Conclusion During the non-clinical toxicological study of radiopharmaceuticals,rational dose design and protective measures should be carried out according to the nature of nuclides and labelled substrates.It could ensure the safety and efficiency of the experimental results.And at the same time,individual dose monitoring and pollution monitoring should be strictly carried out to ensure the radiation safety of operators.
作者 孙鸽 许文黎 黄立群 高洁 尹晶晶 张亚娟 秦秀军 张伟 李建国 安全 SUN Ge;XU Wenli;HUANG Liqun;GAO Jie;YIN Jingjing;ZHANG Yajuan;QIN Xiujun;ZHANG Wei;LI Jianguo;AN Quan(Drug Safety Evaluation Center in China Institute for Radiation Protection,Shangxi Taiyuan 030006,China;Shanxi KeyLaboratory of Drug Toxicology and Drug for Radiation Injury,Division of Radiology and Environmental Medicine of China Institute for Radiation Protection,Shangxi Taiyuan 030006,China)
出处 《中国药物警戒》 2019年第1期23-26,31,共5页 Chinese Journal of Pharmacovigilance
基金 国防科工局核能开发项目:放射性药物安全性评价关键技术研究 中国辐射防护研究院院基金项目:放射性药物安全评价研究 山西省科技基础条件平台项目(201805D141007)
关键词 放射性显影剂 血管刺激 辐射监测 表面污染 辐射防护 radiocontrast medium vascular stimulation radiation monitoring surface contamination radioprotection
  • 相关文献

参考文献5

二级参考文献21

  • 1中华人民共和国卫生部.GBZ 133-2009医用放射性废物管理卫生防护标准[S].北京:中国标准出版社,2009.
  • 2中华人民共和国卫生部.GB 4792-84放射卫生防护基本标准[S].北京:中国标准出版社,1984.
  • 3中华人民共和国卫生部.GBZ 120-2006临床核医学卫生防护标准[S].北京:中国标准出版社,2006.
  • 4CPG. Sec. 420.400 Performance of Tests for Compendial Require-ments on Compendial Products [EB/OL]. (2010-01-12) [2014-03-26].http://www .fda.gov/iceci/compliancemanuals/compliancepoli-cyguidancemanualAicm074370.htm.
  • 5USPC- Governance [EB/OL]. [2014-03-26]iittpy/www.usp.org/about~usp/leadership/govemance.
  • 6操洪欣.药品质量标准[EB/C)L].(2011-01-15)[2014-03-26].http://www.doc88.com/p-714689146410.html.
  • 7胡江滨对接国际标准促进中国医药产业升级-美国药品相关标准内容分析和制定情况介绍[EB/OL].(2010-12-02)[2014-03-26]. http://www.pharmacy.hc360.com/10daquan/secondmenu/Detail一yjbg5 .html.
  • 8USPC, USP Guideline for Submitting Requests for Revision to USP-NFV5 January 2011[EB/OL].(2011-05-27)[2014-03-26].http://www.usp.org/sites/default/files/usp_pdf/EN/USPNF/usp_rfr_general_info_for_aILsubmissions_v5Jan_2011.pdf.
  • 9USPC. PENDING MONOGRAPHS GUIDELINE [EB/OL].( 2011-ll-01)[2014-03-26].http://www.usp.org/sites/default/files/usp_pdf/EN/USPNF/2011-ll-01_pending_monographs_guideline_ver-sion_2.7.pdf.
  • 10USPC. USP Guideline on Use of Accelerated Processes for Revi-sions to the USP-NF Version 3.0 [EB/OL].( 2012-08-31)[2014-03-26].http^/www.usp.org/sites/default/files/usp_pdf/EN/USPNF/2012-08-3 l_guideline_on一use 一of一accelerated一processes 一v3 .pdf.

共引文献27

同被引文献13

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部